In this study, we aimed to elucidate the potential regulatory role of APOH in MASLD development and investigate the association between APOH levels, hepatocyte steatosis, and gut microbiota dysbiosis. Here, APOH is linked to metabolic dysfunction-associated steatotic liver disease.